Skip to Content
Merck
All Photos(2)

Key Documents

GF21658642

Samarium

foil, not light tested, 25x25mm, thickness 0.025mm, as rolled, 99%

Synonym(s):

Samarium, SM000200

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
Sm
CAS Number:
Molecular Weight:
150.36
MDL number:
UNSPSC Code:
12141612
PubChem Substance ID:
NACRES:
NA.23

Assay

99%

form

foil

manufacturer/tradename

Goodfellow 216-586-42

resistivity

91.4 μΩ-cm, 0°C

size × thickness

25 x 25 mm × 0.025 mm

bp

1794 °C (lit.)

mp

1074 °C (lit.)

density

7.47 g/mL at 25 °C (lit.)

SMILES string

[Sm]

InChI

1S/Sm

InChI key

KZUNJOHGWZRPMI-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Pictograms

Flame

Signal Word

Warning

Hazard Statements

Hazard Classifications

Water-react 3

Storage Class Code

4.3 - Hazardous materials which set free flammable gases upon contact with water

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

A N Serafini
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 45(1), 91-99 (2001-07-18)
Various radioisotopes conjugated to pyrophosphate analogues have been developed for systemic metabolic radiotherapy. Samarium-153-EDTMP is a 1:1 complex of radioactive Samarium-153 and a Tetraphosphonate [ethylenediamine-tetramethylene phosphonic acid (EDTMP)]. Samarium Sm-153-EDTMP has a high affinity for skeletal tissue and concentrates by
Masakazu Sono
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 123(8), 653-663 (2003-08-23)
Samarium (II) iodide has been employed to promote the vinylogous pinacol coupling reaction of aldehyde to alpha, beta-unsaturated ketones. The diastereoselectivity of 6-endo-trig mode products was changed by the addition of a proton source and/or HMPA and by the reaction
Pete Anderson
Expert opinion on pharmacotherapy, 7(11), 1475-1486 (2006-07-25)
Samarium-153 lexidronam (153Sm-EDTMP) is FDA approved for painful osteoblastic bone metastases that image on bone scan. 153Sm-EDTMP decay has a therapeutic beta-emission and a gamma-photon for bone scan imaging. Monitoring of osteosarcoma radiation treatment effectiveness was performed with bone, CT
Pete Anderson et al.
Expert review of anticancer therapy, 7(11), 1517-1527 (2007-11-21)
Radiation therapy can be an effective means to treat bone metastases, which occur in more than 50% of cancer patients. (153)Samarium lexidronam ((153)Sm-EDTMP; Quadramet, Cytogen) is a radiopharmaceutical designed for deposition into bone metastases. Bone scans can identify patients that
Christine Beemelmanns et al.
Chemical Society reviews, 40(5), 2199-2210 (2011-01-19)
In this tutorial review we discuss recent advances in the field of ketyl-(het)arene cyclisations promoted by samarium diiodide and related processes. Couplings of samarium ketyls with carbon-carbon multiple bonds are perhaps the most useful reactions to create carbocycles and heterocycles

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service